Compare CRNX & COLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | COLM |
|---|---|---|
| Founded | 2008 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 2.9B |
| IPO Year | 2018 | 1997 |
| Metric | CRNX | COLM |
|---|---|---|
| Price | $33.73 | $54.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 8 |
| Target Price | ★ $74.78 | $60.86 |
| AVG Volume (30 Days) | ★ 1.0M | 504.8K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.24 |
| Revenue | $1,039,000.00 | ★ $3,042,478,000.00 |
| Revenue This Year | $722.66 | $3.73 |
| Revenue Next Year | $183.79 | $3.04 |
| P/E Ratio | ★ N/A | $16.94 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.10 | $47.48 |
| 52 Week High | $57.99 | $77.68 |
| Indicator | CRNX | COLM |
|---|---|---|
| Relative Strength Index (RSI) | 29.20 | 33.25 |
| Support Level | $33.23 | $53.96 |
| Resistance Level | $37.23 | $55.03 |
| Average True Range (ATR) | 1.62 | 1.36 |
| MACD | 0.13 | -0.14 |
| Stochastic Oscillator | 8.33 | 3.66 |
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.